Macrofocal myocardial infarction and hyperglycemia
Abstract
The results of examination of 170 patients with acute myocardial infarction (MI) without previous carbohydrate metabolism disorders are presented in the article. Hyperglycemia in case of MI leads to unfavourable prognostic changes in inflammation and hemostasis parameters. Patient outcomes and homeostasis parameter changes have been revealed depending on the dynamics of glycemia in the acute period of MI.
About the Authors
E. S. Smirnova
Belarusian State Medical University
Belarus
Belarus
N. P. Mitkovskaya
Belarusian State Medical University
Belarus
Belarus
L. I. Danilova
Belarusian Medical Academy of Postgraduate Education
Belarus
Belarus
L. V. Kartun
Belarusian State Medical University
Belarus
Belarus
References
1. Dostizheniya kardiologicheskoi sluzhby Respubliki Belarus' / A. G. Mrochek [i dr.] // Kardiologiya v Belarusi. -2012. - № 4. - S. 8-21.
2. Kliniko-biokhimicheskie osobennosti techeniya ostrogo perioda infarkta miokarda u bol'nykh s metabolicheskim sindromom / T. V. Statkevich [i dr.] // Med. zhurn. - 2009. - № 3. - S. 82-85.
3. Otsenka veroyatnosti razvitiya retsidiva okklyuzii infarkt-svyazannoi arterii / N. P. Mit'kovskaya [i dr.] // Ves. NAN Belarusi Ser. med. navuk. - 2014. - № 3. - S. 45-51.
4. Yaroshevich, N. A. Osobennosti uglevodnogo i lipidnogo obmena u molodykh zhenshchin, perenesshikh infarkt miokarda / N. A. Yaroshevich, L. I. Danilova, T. A. Rutskaya // Retsept. - 2009. - № 5. - S. 97-106.
5. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes / M. Kosiborod [et al.] // Circulation. - 2005. - Vol. 111. - P. 3078-3086.
6. Hyperglycemia and acute coronary syndrome. A scientific statement from the American heart association diabetes committee of the council on nutrition, physical activity, and metabolism / P. Deedwania [et al.] // Circulation. - 2008. - Vol. 117. -P. 1610-1619.
7. Admission hyperglycemia predicts in hospital mortality and major adverse cardiac events after primary percutaneous coronary intervention in patients without diabetes mellitus / A. Ekmekci [et al.] // Angiology. - 2014. - Vol. 65, N 2. - P. 154-159.
8. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis / S. Lavi [et al.] // Int. J. Cardiol. - 2008. - Vol. 123. - P. 117-122.
9. Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial / D. Planer [et al.] // Int. J. Cardiol. - 2013. - Vol. 167, N 6. - P. 2572-2579.
10. The effects of acute hyperglycaemia on the in-hospital and long term prognosis in patients with an acute coronary syndrome / L. Bryniarski [et al.] // Kardiol. Pol. - 2011. - N 8. - P. 774-781.
11. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era / N. Wahab [et al.] // J. Am. Coll. Cardiol. - 2002. - Vol. 40. - P. 1748-1754.
12. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year / K. Malmberg [et al.] // J. Am. Coll. Cardiol. -1995. - Vol. 26, N 1. - P. 57-65.
13. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial / V. Ritsinger [et al.] // Lancet. - 2014. - Vol. 2, N 8. - P. 627-633.
14. DIGAMI 2 investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity / K. Malmberg [et al.] // Eur. Heart J. - 2005. - Vol. 26, N 7. - P. 650-661.
15. The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction / N. Cheung [et al.] // Diabetes Care. - 2006. - Vol. 29. - P. 765-770.
16. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction / R. Diaz [et al.] // JAMA. - 2007. - Vol. 298, N 20. - P. 2399-2405.
17. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial / L. Ceremuzynski [et al.] // Cardiovasc. Drugs Ther. - 1999. - Vol. 13, N 3. - P. 191-200.
18. Shakhnovich, R. M. Ostryi koronarnyi sindrom s pod"emom segmenta ST: rukovodstvo dlya vrachei / R. M. Shakhnovich. - M.: GEOTAR-Media, 2010. - 376 s.
19. Mit'kovskaya, N. P. Serdtse i metabolicheskii risk / N. P. Mit'kovskaya, E. A. Grigorenko, L. I. Danilova. -Minsk: Belarus. navuka, 2008. - 277 s.
20. Sootnoshenie pokazatelei sistemnogo vospaleniya, okislitel'nogo stressa i redoks-statusa glutationa u patsientov s ishemicheskoi bolezn'yu serdtsa i sakharnym diabetom 2-go tipa / A. G. Moiseenok [i dr.] // Arterial'naya gipertenziya. - 2013. - T. 19, № 4. - S. 356-366.
21. Oranskii, P. Urovni tsitokinov u bol'nykh Q-pozitivnym infarktom miokarda v syvorotke krovi i kul'turakh mononuklearov krovi / P. Oranskii, R. Khanferyan // Tsitokiny i vospalenie. - 2009. - T. 8, № 2. - S. 31-33.
22. Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris / S. Solheim [et al.] // Scand. J. Clin. Lab. Invest. - 2008. - Vol. 68, N 7. - P. 555-562.
23. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in patients with myocardial infarction treated with primary angioplasty during a 6-month follow-up / L. Karpinski [et al.] // Pol. Arch. Med. Wewn. - 2009. - Vol. 119, N 3. -P. 115-121.
24. Ceriello, A. Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings / A. Ceriello // Diab. Vasc. Dis. Res. - 2008. - Vol. 5. - P. 260-268.
25. Proinflammatory effects of glucose and anti-inflammatory effects of insulin: relevance to cardiovascular disease / P. Dandona [et al.] // Am. J. Cardiol. - 2007. - Vol. 99, suppl. 1. - P. 15B-26B.
26. Ispol'zovanie biomarkerov-tsitokinov v diagnostike i prognozirovanii techeniya infarkta miokarda / M. V. Zykov [i dr.]. - Kemerevo: KemGMA Minzdravsotsrazvitiya, In-t kompleksnykh problem serd.-sosud. zabolevanii, 2011. - 24 s.
27. Markery vospaleniya i dolgosrochnyi prognoz u bol'nykh s ostrym koronarnym sindromom i stabil'noi formoi ishemicheskoi bolezni serdtsa miokarda / E. G. Ponomar' [i dr.] // Kardiol. serdecno-sosud. hir. - 2011. - № 6. -S. 10-15.
28. Prediktory neblagopriyatnykh koronarnykh sobytii u bol'nykh ostrym koronarnym sindromom s pod"emom segmenta ST, podvergshikhsya chreskozhnym koronarnym vmeshatel'stvam / S. A. Berns [i dr.] // Kardiologiya. - 2010. -№ 6. - S. 15-20.
29. Znachenie opredeleniya nitritov-nitratov kak markerov disfunktsii endoteliya pri serdechno-sosudistoi patologii / L. A. Lapshina [i dr.] // Ukr. med. chasop. - 2009. - T. 6, № 74. - S. 49-53.
30. Sikorskii, A. V. Rol' vazoaktivnykh faktorov endoteliya v razvitii arterial'noi gipotenzii u detei / A. V. Sikorskii // Med. zhurn. - 2013. - № 3. - S. 102-106.
31. Skibchik, V. A. Oksid azota u khvorikh na gostrii shfarkt myukarda i tsukrovii dіabet 2-go tipu / A. V. Skibchik // Ukr. med. chasop. - 2007. - № 4 (60). - S. 72-78.
32. Prognosticheskoe znachenie povyshennogo urovnya D-dimera plazmy krovi u bol'nykh ostrym koronarnym sindromom / A. V. Panina [i dr.] // Bull. of Med. Internet Conf. - 2013. - Vol. 3, iss. 6. - P. 954.
33. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome [Elektronnyi resurs] / R. Mjelva [et al.] // Evr. J. Prev. Cardiol. - 2015. - Mode of access: http://www.ncbi.nlm.nih.gov/pubmed/26635361. - Date of access: 29.12.2015.
34. Intensive insulin therapy in critically ill patients / G. Van den Berghe [et al.] // N. Engl. J. Med. - 2001. - Vol. 345, N 19. - P. 1359-1367.
35. Intensive insulin therapy in the medical ICU / G. Van den Berghe [et al.] // N. Engl. J. Med. - 2006. - Vol. 354, N 5. - P. 449-461.
36. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm / G. Van den Berghe [et al.] // Diabetes. - 2006. - Vol. 55. - P. 3151-3159.
37. Intensive versus conventional glucose control in critically ill patients / S. Finfer [et al.] // N. Engl. J. Med. - 2009. -Vol. 360, N 13. - P. 1283-1297.
38. Standards of medical care in diabetes - 2013 / R. Austin [et al.] // Diabetes Care. - 2013. - Vol. 36, N 1. - P. S11-S110.
39. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL / A. Goyal [et al.] // Eur. Heart J. - 2006. - Vol. 27. - P. 1289-1297.
40. Glucose normalization and outcomes in patients with acute myocardial infarction / M. Kosiborod [et al.] // Arch. Intern. Med. - 2009. - Vol. 169, N 5. - P. 438-446.
Review
For citations:
Smirnova E.S., Mitkovskaya N.P., Danilova L.I., Kartun L.V. Macrofocal myocardial infarction and hyperglycemia. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2016;(1):30-38. (In Russ.)
Views:
797
ISSN 1814-6023 (Print)
ISSN 2524-2350 (Online)
ISSN 2524-2350 (Online)
Email this article 